Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Fri, 25.07.2025
ABIVAX
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)
PARIS, France, July 25, 2025 – 08:00 a.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that h [ … ]
Fri, 25.07.2025
Steyr Motors AG
Steyr Motors also Expands in Maritime Applications – Supply Agreements Exceeding EUR 20 Million Signed
New framework agreements with partners in the United Kingdom, Italy, France, and China
Delivery of 600 inboard diesel engines worth more than EUR 20 million
Targeted diversification of growth creates a stable foundation for the future
Steyr, Au [ … ]
Fri, 25.07.2025
TRATON SE
TRATON GROUP increases incoming orders significantly in a mixed first half of 2025
Incoming orders rose by 11% to 139,600 vehicles in the first half of 2025
Unit sales were down 4% year-on-year to 153,100 vehicles
The Group’s sales revenue declined by 6% to €21.9 billion
Adjusted operating result came in at €1.4 billion, a decrease of €750 mi [ … ]
Fri, 25.07.2025
Palfinger AG
PRESS RELEASE Bergheim, Austria. July 25, 2025PALFINGER: Increased order intake and strong service business in 1st HY 2025
Revenue of EUR 1,139.5 million, EBIT of EUR 90.4 million, and consolidated net result of EUR 50.1 million in line with forecast
Increasing order intake in core European markets
Investments in the g [ … ]
Fri, 25.07.2025
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 LR
July 25, 2025
BB Biotech AG publishes its interim report
BB Biotech AG (ISIN CH0038389992) today published its interim report as at June 30, 2025, which covers the results of its business activities for the first six months of 2025.
Based on the consolidated accounts of BB Biotech AG, net loss for the [ … ]
Fri, 25.07.2025
BB BIOTECH AG
Media release as at July 25, 2025
BB Biotech Q2 2025: outperforms Nasdaq Biotech Index; strong USD returns, currency drag in CHF
Share price +10.2 % USD / -1.1% CHF / +0.8% EUR; discount to NAV tightens to 10.5%
NAV +5.8% USD / -5.1% CHF / -2.8% EUR; beating NBI by 5.9 percentage points
Net loss of CHF 100 mn in Q2; FX the main drag (USD vs CHF [ … ]
Fri, 25.07.2025
Branicks Group AG
Branicks Group AG: Sale of office building at Offenbacher Kaiserlei
Frankfurt am Main, 25 July 2025
Press release
Branicks Group AG: Sale of office building at Offenbacher Kaiserlei
Frankfurt, 25.07.2025 - Branicks Group AG (Branicks), ISIN: DE000A1X3XX4, is selling its majority stake in a building complex at Offenbacher Kaiserlei in the form [ … ]
Fri, 25.07.2025
HELLA GmbH & Co. KGaA
Lippstadt (Germany)
25 July 2025
FORVIA HELLA presents half-year results for 2025: Sales at previous year's level, largely stable earnings development; outlook is confirmed
Group sales of €4.0 billion in the first half of the year
Operating income of €237 million, operating income margin at 6.0 percent
Cash flow improves significantly: [ … ]
Fri, 25.07.2025
Zehnder Group AG
Group sales rose by 11% to EUR 382.8 million in the first half of 2025
Strong sales increase in the ventilation segment of 24% (organically +15%1) to EUR 254.1 million; ventilation sales rose to 66% (previous year: 59%) of total sales
Operating result (EBIT) was EUR 32.7 million (+45%); EBIT margin of 8.5%; no one-off effects in the first half of [ … ]
Fri, 25.07.2025
Orell Füssli AG
Ad hoc announcement pursuant to Art. 53 LR
Orell Füssli Continues on its Growth Path
Increase in revenue and EBIT in the first half of the year
Growth and high capacity utilisation in security printing
Book retailing further expands market position
Publishers expand portfolio thanks to acquisition of Verlag SKV AG
Procivis focuses on increa [ … ]
